MedTrace Logo

Induction of Labor in Term Pregnancies With Unfavourable Cervix

NCT04280874 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 212

Last updated 2020-07-21

No results posted yet for this study

Summary

This is a prospective randomized trial comparing two prostaglandin E2 (dinoprostone) agents used for labor induction in pregnant women with term pregnancies and unfavorable cervix.

Conditions

  • Induction of Labor Affected Fetus / Newborn
  • Prostaglandins Causing Adverse Effects in Therapeutic Use

Interventions

DRUG

Dinoprostone 0.5 MG

0.5mg dinoprostone applied intracervically

DRUG

Dinoprostone 2 MG/2.5 ML Vaginal Gel/Jelly

2mg dinoprostone applied intravaginally

Sponsors & Collaborators

  • Clinical Hospital Merkur

    lead OTHER

Principal Investigators

  • Katja Vince, MD · Clinical Hospital Merkur

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-10
Primary Completion
2020-07-01
Completion
2020-07-01

Countries

  • Croatia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04280874 on ClinicalTrials.gov